Objectives. This study assessed changes in coronary flow velocity measured distal to a significant stenosis of the left anterior descending coronary artery and at the adjacent normal left circumflex coronary artery, produced by intravenous administration of dipyridamole, in patients undergoing coronary angioplasty with a documented perfusion defect on dipyridamole-thallium-201 scintigraphy.
Intravenous dipyridamole has been used to produce coronary vasodilation in the context of a variety of cardiac imaging procedures, such as thallium-201 scintigraphy, two-dimensional echocardiography and positron emission tomography (1) (2) (3) (4) (5) (6) (7) . Various techniques, such as thermodilution-estimated coronary sinus blood flow, digital subtraction angiography, intracoronary Doppler measurements and positron emission tomography, have been applied to measure coronary blood flow in humans (8) (9) (10) (11) (12) (13) (14) (15) . However, these techniques cannot reliably measure differences of flow across a stenosis. Recently it has become possible to assess the intracoronary flow velocity directly proximal and distal to a stenosis in humans using a Doppler-tipped flexible guide wire (16, 17) .
In the present study we utilized the Doppler guide wire with the aim of comparing the changes in coronary flow velocity measured simultaneously 1) at a segment distal to a significant stenosis, and 2) at an adjacent normal coronary artery pro-duced by the intravenous administration of dipyridamole in patients undergoing coronary angioplasty. These patients had a defect previously documented with dipyridamole administration on thallium-201 single-photon emission computed tomography (SPECT) imaging. Our aim was to document that this defect had been caused by flow inhomogeneity.
Methods
Study patients. Seventeen patients (15 men, 2 women; mean age [_+SD] 57 _+ 9 years, range 41 to 77) who were undergoing elective coronary angioplasty because of stable angina pectoris refractory to medical treatment and lumen diameter stenosis ---50% in the left anterior descending coronary artery with a normal adjacent left circumflex coronary artery were prospectively studied ( Table 1) . All patients had shown reversible perfusion defects on thallium-201 scintigraphy, after intravenous administration of dipyridamole performed within 24 to 48 h before angioplasty. None had a clinical history or electrocardiographic (ECG) signs of a previous myocardial infarction, history of systemic hypertension (arterial pressure ->150/95 mm Hg) or evidence of primary myocardial or valvular heart disease. No patient had anemia (hemoglobin level <10.0 g/dl) or evidence of left ventricular hypertrophy (septal or posterior wall thickness >11 mm) on echocardiographic examination. Completely occluded vessels were excluded from the study. No patient had angiographically visible collateral flow to the stenosed artery territory or evidence of thrombus at the stenosed artery. Cardiac medications were interrupted 1 day before the study, and drugs or foods containing methylxanthine compounds were withheld for at least 18 h. No patient received narcotic medications for analgesia or atropine before the procedure. Intracoronary nitrates (200/~g) were administered before dipyridamole infusion to abolish the epicardial vasodilator action of the drug. The study protocol was approved by the Ethics Committee of our institution, and all patients gave written informed consent to the study.
Catheterization procedure. After systemic anticoagulation with 10,000 IU of heparin administered intravenously, the left main stem was cannulated with an 8F giant lumen Judkins guiding catheter (Cordis Inc.). A 0.014-in. (0.36-mm) Doppler angioplasty guide wire was advanced to a segment of the left anterior descending coronary artery 5 to 10 artery diameters beyond the stenosis. A second 0.014-in. Doppler guide wire was positioned in the normal proximal or midsegment of the adjacent circumflex artery. Care was taken to avoid deep cannulation of the guiding catheter into the left coronary artery to prevent limitation of flow during maximal hyperemia. Heart rate, surface ECG (leads I, aVE, Vs) and aortic blood pressure as obtained from the guiding catheter were continuously recorded on a multichannel recorder. After baseline acquisition of flow velocity, heart rate and arterial pressure for a time interval of 5 min, dipyridamole was administered with a controlled-infusion pump system in the standard dose of 0.56 mg/kg body weight intravenously over a period of 4 min. The changes in coronary flow velocity and hemodynamic measurements were obtained simultaneously in both arteries every 2 min for a total time period of 10 min. The contrast medium used in all patients was ioxaglate sodium (Hexabrix R). Care was taken to withhold any contrast injection for 5 rain before flow measurements. All angiograms were reviewed by two experienced interventional cardiologists (V.V., A.M.). The lumen diameter of the stenosed artery at the proximal and distal segments and at the site of the stenosis, in the projection showing the maximal severity, was measured at end-diastole using electronic calipers. The dimension of the guiding catheter was used to correct for differences in magnification. Analysis of intraobserver and interobserver variability for the measurement of the coronary artery diameter with this technique showed high reproducibility (r = 0.99, SEE 0.06, p < 0.01 and r = 0.98, SEE 0.05, p < 0.01, respectively).
Doppler guide wire and coronary flow velocity measurements. The Doppler angioplasty guide wire is 0.014-in., 175 cm long, flexible and steerable, with a 15-MHz piezoelectric ultrasound transducer integrated on the tip (FloWire, Cardiometrics Inc.). The ultrasound beam diverges at 28 ° from the Doppler transducer, and the sample volume was positioned at a distance of 4.2 mm from the transducer to avoid the area of distortion of flow profile caused by the presence of the guide wire. The signal transmitted from the piezoelectric transducer is processed from the Doppler audio signal by a real-time spectral analyzer using on-line fast Fourier transform algorithm (FloMap, Cardiometrics Inc.). This system displays several spectral variables on-line, including the time-averaged peak velocity (mean of 2 beats in cm/s) and the diastolic/ systolic velocity ratio. Velocity data are recorded on 0.5-in. videotape, and single-frame images can be printed for off-line analysis. The Doppler guide wire has been validated during intravascular measurements of coronary artery flow velocity by Doucctte et al. (18) . The coronary flow velocity reserve was defined as the ratio between the time-averaged peak velocity at peak hyperemia and the time-averaged peak velocity at baseline. On the basis of previous studies, both by Miller et al. (19) and in our own laboratory (50 measurements), normal coronary flow velocity reserve was defined as >2.0. The relative flow reserve was defined as the quotient of coronary flow velocity reserve at the distal segment of the stenotic vessel and coronary flow velocity reserve at the adjacent normal vessel.
Thallium.201 seintigraphy. All patients underwent dipyridamole-thallium-201 scintigraphy 24 to 48 h before angioplasty (20, 21) . Dipyridamole was infused intravenously at the standard dose of 0.56 mg/kg over 4 rain. At the completion of the infusion, 3 mCi of thallium was injected. Five to 10 rain after thallium-201 injection, the patient was brought to a supine position, and imaging was started. During the first 20 min, the ECG, blood pressure and heart rate were recorded every minute. Thallium-201 scintigraphy was performed using a large field of view rotating gamma camera (Orbiter Siemens) equipped with a low energy, high resolution collimator interfaced to a computer (ICON). Thirty-two frames were obtained over a 180 ° arc, from the 45 ° left posterior oblique to the 45 ° right anterior oblique position, at 6 ° intervals, for 40 s/frame. The data were stored on 64 × 64 × 8-byte matr~ Imaging was repeated 4 h later to assess defect reversibility (22, 23) . The myocardial segments and coronary arteries were matched with the following classification: septal and anterior segments corresponded to the left anterior descending; inferior, inferoapical and posterior segments to the right; and lateral segments to the left circumflex coronary arteries. Myocardial uptake of thallium-201 was also quantified using twodimensional polar plots depicting the three-dimensional thallium distribution. The polar plots obtained for each individual patient were statistically connected with a normal data bank. Myocardial pixels with counts <2.5 SD from the mean values of the corresponding pixels in the normal data bank were considered abnormal and coded as such by the computer software. The thallium-201 relative perfusion ratio was defined as the ratio of the activity (counts/pixel) of the involved segments (anterior and septal) to uninvolved segment (lateral) during hyperemia, divided by the same ratio on the delayed images.
Statistical analysis.
All data are expressed as mean value _+ SD. Two-tailed paired and unpaired Student t tests were used to compare the significance of the differences between flow velocity measurements at baseline and after dipyridamole infusion. Analysis of variance for repeated measurements was used for simultaneous comparison of more than two mean values. A nonparametric test (Mann-Whitney rank test) was used to compare differences in the degree of the stenosis between patients with and without angina pectoris and ECG changes during dipyridamole infusion. Simple linear and nonlinear regression analysis was performed to correlate flow velocity variables, thallium-201 quantitative measurements and angiographic data. Statistical significance was defined at p < 0.05.
Results
All patients studied had severe stenoses of the left anterior descending coronary artery. Mean percent diameter stenosis was 85.12 + 10.35%, with mean minimal lumen diameter 0.41 _+ 0.31 ram. The location of the stenosis was the proximal segment of the left anterior descending artery in 7 patients and the midsegment, after the origin of the first septal branch or a diagonal branch, in the remaining 10. Mean global ejection fraction at rest in the right anterior oblique projection was 55.4 + 8.4%.
Clinical, ECG and hemodynamic changes during dipyridamole infusion. During catheterization, intravenous dipyrida-
mole produced an increase in heart rate from 74 _+ 13 to 97 _+ 16 beats/rain (p < 0.001). Mean aortic blood pressure decreased from 103 _+ 15 to 95 -18 mm Hg (p = NS), systolic pressure from 137 _+ 20 to 129 _+ 23 mm Hg (p = NS) and diastolic aortic pressure from 76 _+ 12 to 70 _+ 15 ram Hg (p = NS). The rate-pressure product was 10,329 _+ 2,376 mm Hg/min at baseline and 12,271 _+ 2,534 rnm Hg/min during maximal vasodilation (p < 0.001). Similarly, on thallium-201 imaging, no significant difference was noted between mean aortic blood pressure at rest and during dipyridamole infusion (from 101 _ 14 to 96 _ 15 mm Hg), whereas heart rate was increased from 68 _+ 11 beats/rain at rest to 100 _+ 14 beats/rain during hyperemia (p < 0.001). More important, at rest and during maximal hyperemia, mean aortic blood pressure, heart rate and rate-pressure product did not differ significantly during thallium-201 seintigraphy and during catheterization. Electrocardiographic changes suggestive of isehemia (ST segment depression >0.1 mV) were seen in five patients in lead Vs, and anginal pain occurred in eight patients during dipyridamole infusion.
Regional coronary flow velocity measurements.
At baseline, the time-averaged peak velocity at the segment distal to the stenosis was 7.24 _+ 3.7 cm/s, and that at the adjacent normal left circumflex coronary artery 18.88 -+ 7.1 cnl/s (p < 0.001). After dipyridamole administration, a small increase in blood flow velocity was observed at the segment distal to the stenosis (5.5 _+ 33.7%). In contrast, a large increase was observed after dipyridamole in the adjacent normal left circumflex coronary artery, with a more than twofold increase in flow velocity from baseline (162.4 +_ 39.8%) ( Table 2 , and Fig.  1 ). In seven patients it actually decreased; this flow decrease was accompanied by anginal pain in four patients and ECG ischemic changes in two. The coronary flow velocity reserve was significantly lower at the distal segment of the stenosed artery than at the adjacent normal coronary artery (1.06 _+ 0.34 vs. 2.63 + 0.39, p < 0.001). The diastolic/systolic velocity ratio did not change significantly from baseline to hyperemia either at the normal coronary artery (1.78 _+ 0.7 to 1.73 _+ 0.5) or at the segment distal to the stenosis (0.93 _+ 0.2 to 0.84 -+ 0.3). The time response of the flow velocity changes during dipyridamole infusion and at the following 6 rain is depicted in Figure 2 . The maximal increase in flow velocity was seen 2 to 4 min after completion of the dipyridamole infusion in both arteries. A significant flow velocity increase was obtained in the left circumflex artery (p < 0.001) in contrast to a nonsignificant change observed in the left anterior descending coronary artery. There was no difference in flow velocity variables at rest or after maximal hyperemia between patients with angina and without angina or in patients with and without ST segment depression in lead V5 during dipyridamole infusion.
Coronary flow velocity and angiographic correlations. At the segment distal to the stenosis, the time-averaged peak velocity and the diastolic/systolic velocity ratio at baseline and after maximal hyperemia did not correlate with the degree of the stenosis expressed as percent of vessel diameter. In contrast, distal coronary flow velocity reserve showed a significant correlation with percent of vessel diameter stenosis (r = -0.66, p < 0.05, Fig. 3 ). A similar correlation was observed between relative flow reserve and degree of stenosis (r = -0.67, p < 0.05). No significant correlation was observed between distal coronary flow velocity reserve and the diastolic/ systolic velocity ratio at baseline or during hyperemia.
Quantitative thallium-201 scintigraphy and correlation with flow velocity measurements. The quotient of mean number of counts/pixel at the segment perfused by the stenotic vessel (anterior and septal) and the mean number of counts/ pixel at the segment perfused by the normal left circumflex coronary artery (lateral) was 0.48 + 0.14 at the peak effect of dipyridamole and 0.78 -+ 0.11 on the delayed images (p < 0.001) ( Table 1) . A strong correlation was found between the relative flow reserve estimated by flow velocity measurements using the Flowires and the thallium-201 relative perfusion ratio derived from quantitative thallium scintigraphic measurements (r = 0.90, p < 0.001) ( Fig. 4) . A similarly strong correlation was observed between relative flow reserve and the ratio of eounts/pixel in the involved segment and counts/pixel in the uninvolved segment at peak hyperemia alone (r = 0.86, p < o.ool).
Discussion
In the present study two intracoronary Doppler-tipped guide wires were used to assess coronary flow velocity simultaneously at two different sites, at rest and after intravenous infusion of dipyridamole. The time-averaged peak velocity, measured at the segment distal to the stenosis at rest, was lower than at the proximal/midsegment of the adjacent normal left circumflex coronary artery, a finding that has been previously reported (12, 24, 25) . The systemic effects of dipyridamole infusion were similar to those reported in other studies with a significant increase in heart rate and no significant changes in aortic blood pressure (26) (27) (28) . More important, mean aortic blood pressure, heart rate and rate-pressure product did not differ significantly during thallium-201 scintigraphy and during catheterization. Coronary flow reserve. The quantitative flow velocity measurements in our patients during hyperemia demonstrate a lack of flow increase in a zone supplied by a stenotic vessel with simultaneous increase of flow to the zones perfused by a normal vessel. This is the first direct proof of flow inhomogeneity produced by intravenous dipyridamole in normal and diseased coronary arteries. Normal coronary flow reserve derived indirectly using coronary angiography or positron emission tomography varies from 2.5 to 5.5 (29) (30) (31) (32) ; by using Doppler catheters (3F), values ranged from 3.5 to 5.5 (14, 28) , contrary to those recorded using a Doppler guide wire, which yields values from 2.0 to 3.0 (24, 25) . In contrast, in the presence of a flow-limiting stenosis, the ability to achieve such a maximal augmentation in coronary flow after coronary vasodilation is limited, because resistance vessels have already undergone compensatory vasodilation in an attempt to maintain flow (33) . In previous studies (34) using indirect methods, it has been shown that inequalities of regional myocardial perfusion may be detected with thallium-201 if hyperemic flow in normally perfused myocardium exceeds that in diseased regions by a factor of 2, a condition that was more than met in our study. Coronary "steal phenomenon." In seven of our patients a decrease in the coronary flow velocity at peak hyperemia distal to the stenosis was observed. In these patients, the "steal phenomenon" can be postulated. Coronary steal (35) (36) (37) has been defined as an increase in flow to nonischemic myocardium at the expense of decreasing flow to ischemic myocardium (horizontal steal); another type of coronary steal, subendocardial to subepicardial, has also been described (vertical steal). Both types may occur in a given patient, depending on the extent and severity of the coronary artery disease. Quantitative demonstration of horizontal steal has remained elusive because of methodologic problems. In a previous report, Kern et al. (38) described a case in which steal across the stenosis has been confirmed using continuous dual Flowire spectral coronary flow measurements performed proximal and distal to the stenosis segment of the first marginal branch during intracoronary adenosine and intravenous dipyridamole infusions.
Correlations between anatomic and physiologic data. We found a significant correlation between the severity of coronary artery stenosis, as expressed by the percent of the vessel diameter and poststenotic coronary flow velocity reserve. Similar results have been reported by Miller et al. (19) using the same technique. Nevertheless, some investigators (4, 39) have reported a poor correlation between the effect of a stenosis on flow behavior and its anatomic characteristics, and they have suggested that relative rather than absolute estimates of myocardial perfusion reserve might be a more sensitive descriptor of the physiologic consequences of angiographic stenosis severity. Up to now these measurements of relative perfusion reserve have been performed with positron emission tomography using different tracers (30, (40) (41) (42) . In our study the percent vessel diameter stenosis showed a strong correlation with the relative flow reserve as well as with the poststenotic coronary flow velocity reserve. Another important finding of our study is the strong and very significant correlation observed between the relative flow reserve and the thallium-201 relative perfusion ratio derived by quantitative measurements on thallium-201 scintigraphy. This correlation still existed when the scintigraphic activity during hyperemia alone was considered and has, to our knowledge, not been reported up to now. In a recent study, Joye et al. (43) , in patients with intermediate coronary artery stenoses, found a perfusion defect in 15 of 16 vascular territories with an abnormal coronary flow reserve, but only in 1 of 19 territories with a normal coronary flow reserve, although the degree of the stenosis was similar in the two groups. It is worth mentioning that in our patient group with severe coronary stenoses, the functional hemodynamic assessment with the Flowire correlates better with the scintigraphic perfusion data than with the angiographically determined severity of the stenosis. This may have implications in the a priori acceptance of coronary angiography as the reference standard in the functional evaluation of patients with advanced coronary artery disease.
Study limitations. Technical factors related to obtaining flow velocity measurements, such as potential aliasing effects and spectral analysis of the signal, are minor with this technique and its large Doppler sample volume, but they still exist. The simultaneous use of two Flowires was satisfactory in our patients but may be compromised by signal interference or transient loss of signal as a result of wire rotation or motion artifact.
Changes in coronary flow velocity during intravenous dipyridamole infusion may not reflect changes in volumetric flow if the medication also alters the lumen diameter of the coronary artery at the site of Doppler measurements. No angiography was performed at the maximal effect of dipyridamole infusion in our study. However, previous studies have demonstrated no change or minimal changes in coronary diameter following intravenous adenosine or dipyridamole administration (24, 28, 44) . Ogilby et al. (45) suggested that slight vasodilation may occur in both normal and stenotic segments; as a result, the percent diameter stenosis is not essentially altered. Thus, any increase in coronary flow velocity after dipyridamole infusion may not have essentially influenced our results. It is possible, however, that obstruction of the lesion by the Doppler guide wire may have resulted in hyperemic flow reduction, although this guide wire has a minimal diameter (0.014 in.) compared with previously used Doppler catheters. In a recent study, De Bruyne et al. (46) have reported that in patients with isolated very tight stenoses of the left anterior descending artery and normal left ventricular function, the presence of the pressure-monitoring guide wire (diameter 0.015-in. [0.38 mm]) through the lesion did not induce a large overestimation of the actual pressure gradient.
Another limitation of the study is that the dose of dipyridamole used (0.56 mg/kg) may have produced submaximal vasodilation in some patients. Evidence for submaximal coronary vasodilation after administration of dipyridamole in the standard dose of 0.56 mg/kg has been reported by other investigators (2, 47) . The hyperemic flow velocities in the normal coronary artery of our study group were similar to those previously reported (16, 48) . Furthermore, any submaximal effect of dipyridamole infusion may have had a similar impact on the two studied arteries; this dose is the one most widely used in thallium-201 imaging studies, although larger doses are used during echocardiography. We did not perform a coronary flow reserve measurement using either intracoronary adenosine or papaverine for comparison before dipyridamole infusion. The comparison of dipyridamole with intracoronary adenosine or papaverine hyperemia has been reported, and in general adenosine achieves similar maximal flow velocities to dipyridamole in normal vessels (40, 49) . Finally, we used hand-held electronic calipers to measure the degree of coronary artery stenosis. Although this technique, for stenoses >80% diameter narrowing, is fraught with technical difficulties, strong intraobserver and interobserver variability has been reported (50) .
Conclusions. Flow inhomogeneity was documented in selected patients with Severe stenoses of the left anterior descending and normal left circumflex coronary arteries by direct flow velocity measurements, corresponding to thallium defects. A low poststenotic flow velocity reserve coupled with a normal coronary flow velocity reserve in an adjacent unaffected zone of myocardium does represent the mechanism by which dipyridamole-thallium scanning results are positive. The issue regarding whether this represents true isehemia or not cannot be addressed by this study.
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